| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
School of Allied Health, University of Connecticut (J.E.K.), Storrs, Connecticut 06269; the Departments of Internal Medicine (M.E.M., A.F.E., K.L.I.), Orthopedics and Rehabilitation (C.M.G.), and Pediatrics (T.O.C.), Yale University School of Medicine, New Haven, Connecticut 06520; and the Adult Clinical Research Center and Food and Nutritional Services, Yale University School of Medicine and Yale New Haven Hospital (D.M.C.), New Haven, Connecticut 06504
Address all correspondence and requests for reprints to: Dr. Jane E. Kerstetter, School of Allied Health, U-2101, 358 Mansfield Road, University of Connecticut, Storrs, Connecticut 06269-2101.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Although changes in mineral metabolism clearly attend alterations in dietary protein intake, the long term implications for skeletal health are uncertain. Cross-sectional studies evaluating bone mineral density as a function of historical protein intake have yielded conflicting results (6, 7, 8, 9, 10, 11). Studies examining the association between protein intake and fracture incidence, however, have generally observed a positive association (12, 13). We have reported a significant cross-cultural association between dietary animal protein intake and the age-adjusted incidence of hip fracture (14). None of these data provides direct evidence for a causal relationship between protein intake and fracture.
Over 25 yr ago, Wachman and Bernstein (15) proposed that the skeleton played a role in acid-base homeostasis. They suggested that skeletal stores of base in the form of calcium salts could be called upon to neutralize endogenous acid loads generated from high protein diets. The long term result would be accelerated rates of skeletal loss (16, 17). Further, the diminished ability of the kidney to excrete fixed acid loads with aging may lead to increasing dependence on buffering from bone with a deleterious long term effect on skeletal mass (18). If this hypothesis is correct, one would expect to see changes in bone turnover and, more specifically, an increase in bone resorption with the long term ingestion of high protein diets. Biochemical studies addressing this question are limited. Schuette and colleagues (19) and Chan and Swaminathan (20) reported that urinary hydroxyproline excretion increased with increasing levels of dietary protein intake, whereas Shapses et al. (21) found no impact of increasing levels of dietary protein on bone turnover. We therefore prospectively examined the effect of dietary protein on markers of bone turnover in healthy young women studied at low, medium, and high levels of protein intake.
| Subjects and Methods |
|---|
|
|
|---|
Subjects
Sixteen healthy women (aged 2040 yr) were recruited to participate in the study. The average age was 26.7 ± 1.3 yr, and they had a body mass index (kilograms per m2) of 22.3 ± 0.6. Exclusion criteria have been previously described (4). Throughout the study, subjects were free living and continued their usual activities at home, school, and work. Informed consent was obtained from each study participant.
Diets
During the 2-week adjustment period, subjects were instructed to self-select their diets to contain approximately 1 g protein/kg, 20 mmol calcium and 100 mmol sodium. Caffeine-containing beverages were limited to one per day, and alcohol was not permitted.
During the 4-day experimental period, subjects reported daily to the GCRC to receive their meals and record their body weights. Each subject began at an energy intake of 125150 kJ/kg, which was adjusted in 840- to 1260-kJ increments (with simple sugars and fats) during the experimental period to maintain body weight within an average of 1% of the initial weight.
All experimental diets consisted of a variety of common foods that were prepared, weighed (to 0.1 g), and served from the GCRC metabolic kitchen under the supervision of the research dietitian. The experimental diets were individually calculated for each subject to contain one of three levels of protein, whereas other nutrients remained constant and controlled (19.820.3 mmol calcium, 2638 mmol phosphorus, and 99101 mmol sodium). Protein intake was low (0.7 g/kg), medium (1.0 g/kg), or high (2.1 g/kg). The source of calcium in the experimental diets was primarily dairy foods and a commercially available, chewable, form of calcium carbonate (Tums, SmithKline Beecham, Pittsburgh, PA). The macronutrient and mineral compositions of the experimental diets were previously reported (4).
Sample collection
Blood and urine samples were collected on days 0 and 4 of each experimental period. On days -1 and 3, subjects collected timed 24-h urine samples for determination of calcium, sodium, and creatinine excretion. On the mornings of days 0 and 4, fasting 2-h urine samples were obtained for determination of cAMP, creatinine, and type 1 collagen N-telopeptide concentrations. Blood was drawn at the midpoint of the 2-h period for the measurement of plasma cAMP, midmolecule PTH, intact PTH, 1,25-dihydroxyvitamin D, total and ionized calcium, phosphorus, creatinine, osteocalcin, and bone-specific alkaline phos- phatase.
Assays
Urinary and blood calcium and creatinine, blood phosphorus, intact PTH-(184), midmolecule PTH, 1,25-dihydroxyvitamin D, and urinary sodium, nitrogen, and nephrogenous cAMP (NcAMP) excretion were determined as previously reported (4). The percent calcium reabsorption during the 2-h fasting urine specimen was calculated using the following formula: 100 - [(urinary calcium ÷ plasma calcium) x (plasma creatinine ÷ urinary creatinine) x 100].
Serum osteocalcin was measured using the method of Gundberg et al. (22), and bone-specific alkaline phosphatase was measured by differential binding to wheat germ lectin (Boehringer Mannheim, Mannheim, Germany) followed by colorimetric assay according to the method of Farley et al. (23). Urinary excretion of the cross-linked N-telopeptide of type 1 collagen was determined using a commercially available enzyme-linked immunosorbent assay (Osteomark, Ostex International, Inc., Seattle, WA). All six samples from a single subject were analyzed in duplicate in the same assay.
Statistical analyses
All values are presented as the mean ± SEM. Within each time point, repeated measures ANOVA was used to evaluate differences between dietary protein levels using SYSTAT for Windows, version 5.0 (Evanston, IL). P < 0.05 indicated statistical significance. When there was an overall effect of protein level, post-hoc orthogonal contrasts were then used to evaluate the differences at each time point. Because multiple contrasts were performed (low vs. medium, medium vs. high, and low vs. high), a Bonferroni correction was applied (24).
| Results |
|---|
|
|
|---|
Changes induced in mineral metabolism and calcitropic hormones
Changes observed in mineral metabolism and calcitropic hormones were presented in detail previously (4). Briefly, baseline measures of these parameters did not differ among the three protein levels. By day 4, urinary calcium was significantly decreased during the low protein diet compared to that during the medium protein diet (low, 108 ± 14 mg/day; medium, 129 ± 14 mg/day; P < 0.05) and was significantly increased during the high protein diet compared to that during the medium protein diet (medium, 129 ± 14 mg/day; high, 196 ± 19 mg/day; P < 0.0005). Urinary sodium did not differ among any of the three experimental diets. The glomerular filtration rate rose as dietary protein increased (low, 85 ± 5; medium, 95 ± 5; high, 107 ± 6 mL/min). Fasting calcium reabsorption was significantly reduced during the high protein diet compared to the medium and low protein diets (high protein diet, 98.99 ± 0.14%; medium protein diet, 99.35 ± 0.10%; low protein diet, 99.42 ± 0.88%; P < 0.05).
As previously reported (4), secondary hyperparathyroidism developed
during the low protein diet. By day 4 of the low protein diet,
circulating levels of midmolecule PTH were 2.4-fold higher than the
mean values during the medium protein diet (37.7 ± 1.9
vs. 15.5 ± 1.0 nmol/L; P < 0.0001).
In every subject consuming the low protein diet, the value for
midmolecule PTH on day 4 exceeded the upper limit of normal (20
nmol/L). Serum levels of intact PTH, 1,25-dihydroxyvitamin D, and NcAMP
were also significantly increased within 4 days of consumption of the
low protein diet (P < 0.005 compared to the medium
diet), consistent with an increase in bioactive PTH. In contrast,
mineral metabolism and calcitropic hormones remained stable during the
medium protein diet. Subjects consuming the high protein diet showed no
change on day 4 in circulating levels of PTH, 1,25-dihydroxyvitamin D,
or NcAMP excretion. However, as reported previously (4), there was a
slight suppression of the PTH-1
-hydroxylase axis when subjects
continued the high protein diet for 14 days.
Changes induced in bone turnover
Baseline values of osteocalcin and urinary
N-telopeptide excretion did not differ among the dietary
treatments (data not shown). In response to increasing dietary protein,
urinary N-telopeptide excretion rose progressively, such
that by day 4 the value was significantly greater during the high
vs. the low protein diet (Table 1
). The frequency distribution of
N-telopeptide excretion during the low and high protein
diets is shown in Fig. 1
. As can be seen,
the frequency distribution of N-telopeptide excretion was
shifted to the right (i.e. toward higher values) on the high
protein diet. Of the 16 women, 12 increased their
N-telopeptide excretion, with the increase ranging from
28327% between the low and high protein diets. The mean day 4
urinary N-telopeptide excretion during the low diet was
lower, although not significantly so, compared to the medium protein
intake. In contrast to the rise in urinary N-telopeptide
excretion, there was no difference in day 4 mean serum osteocalcin
values during any of the three diets. Day 4 values of bone-specific
alkaline phosphatase were higher during the low compared to the
medium protein diet, but were not different between the low and high or
medium and high protein intakes.
|
|
| Discussion |
|---|
|
|
|---|
Experimental studies directly examining the effect of animal protein on bone turnover are limited. Scheutte et al. (19) studied 16 young men during 12 days of low (50 g/day) or high (150 g/day) levels of protein intake with dietary calcium fixed at 500 mg/day. She reported that urinary hydroxyproline increased from 21.4 to 28.2 mg/24 h (a 32% increase) in response to the increase in dietary protein. In contrast, Shapses et al. (21) studied 7 young men and 8 young women and found that urinary hydroxyproline, pyridinoline, and deoxypyridinoline did not increase when dietary protein was increased from 0.44 to 2.71 g/kg. After 5 days on each diet, mean values for each urinary metabolite were not different on the two diets. However, in this study, dietary calcium was increased from 423 to 1589 mg/day concomitant with the increase in dietary protein, potentially obscuring an effect of dietary protein on bone resorption.
Dietary protein may exert a continuum of effects on skeletal
homeostasis involving both intestine and bone. Combined with our
previous studies, the current data suggest the following model to
explain the induced changes in mineral metabolism observed during low,
medium, and high levels of protein intake. A medium protein intake
induces no change in mineral homeostasis, intestinal calcium
absorption, or bone turnover rates. At high levels of dietary protein,
urinary calcium excretion is elevated despite normal intestinal calcium
absorption and in the face of slight suppression of the
PTH-1
-hydroxylase axis (4, 5). As reported in this study, high
levels of dietary protein are associated with increased rates of bone
resorption without an increase in markers of formation. Taken together,
these data suggest that at high levels of dietary protein, at least a
portion of the increase in urinary calcium may reflect increased bone
resorption rates. Recent work by Sebastian et al. (26)
suggesting a reduction in markers of bone resorption in postmenopausal
women supplemented with alkali is consistent with this idea. As noted
in the current study, bone resorption rates were slightly, albeit not
statistically significantly, lower during the low compared to the
medium protein intake. These skeletal effects, in combination with
reduced intestinal calcium absorption (5), probably explain the
secondary hyperparathyroidism observed during the low protein diet. Our
findings raise the possibility that at low levels of dietary protein,
skeletal calcium accretion may be impaired. In this context it is of
interest that Chiu et al. (27) reported reduced skeletal
bone mass in long term vegans. Long term prospective studies are needed
to further explore various components of this hypothesis. Further,
indirect markers of bone resorption and formation may not precisely
reflect what is occurring at the level of skeletal tissue. More direct
methods, such as bone histomorphometry and calcium kinetic studies,
will be required to precisely quantitate the relative contributions of
altered bone metabolism and intestinal calcium absorption to the
observed changes in whole body mineral homeostasis induced by different
levels of dietary protein intake.
| Footnotes |
|---|
Received August 11, 1998.
Revised November 20, 1998.
Accepted December 7, 1998.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. L Darling, D J. Millward, D. J Torgerson, C. E Hewitt, and S. A Lanham-New Dietary protein and bone health: a systematic review and meta-analysis Am. J. Clinical Nutrition, December 1, 2009; 90(6): 1674 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Pye, A. P. Wakefield, H. M. Aukema, J. D. House, M. R. Ogborn, and H. A. Weiler A High Mixed Protein Diet Reduces Body Fat without Altering the Mechanical Properties of Bone in Female Rats J. Nutr., November 1, 2009; 139(11): 2099 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dawson-Hughes, S. S. Harris, N. J. Palermo, C. Castaneda-Sceppa, H. M. Rasmussen, and G. E. Dallal Treatment with Potassium Bicarbonate Lowers Calcium Excretion and Bone Resorption in Older Men and Women J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Z. Budek, C. Hoppe, K. F. Michaelsen, S. Bugel, and C. Molgaard Associations of Total, Dairy, and Meat Protein with Markers for Bone Turnover in Healthy, Prepubertal Boys J. Nutr., April 1, 2007; 137(4): 930 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Zwart, J. E. Davis-Street, D. Paddon-Jones, A. A. Ferrando, R. R. Wolfe, and S. M. Smith Amino acid supplementation alters bone metabolism during simulated weightlessness J Appl Physiol, July 1, 2005; 99(1): 134 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Noakes, J. B Keogh, P. R Foster, and P. M Clifton Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1298 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Devine, I. M Dick, A. F. Islam, S. S Dhaliwal, and R. L Prince Protein consumption is an important predictor of lower limb bone mass in elderly women Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1423 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Ballard, J. A Clapper, B. L Specker, T. L Binkley, and M. D Vukovich Effect of protein supplementation during a 6-mo strength and conditioning program on insulin-like growth factor I and markers of bone turnover in young adults Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1442 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R Zwart, A. R Hargens, and S. M Smith The ratio of animal protein intake to potassium intake is a predictor of bone resorption in space flight analogues and in ambulatory subjects Am. J. Clinical Nutrition, October 1, 2004; 80(4): 1058 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lacroix, C. Gaudichon, A. Martin, C. Morens, V. Mathe, D. Tome, and J.-F. Huneau A long-term high-protein diet markedly reduces adipose tissue without major side effects in Wistar male rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R934 - R942. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Ince, E. J. Anderson, and R. M. Neer Lowering Dietary Protein to U.S. Recommended Dietary Allowance Levels Reduces Urinary Calcium Excretion and Bone Resorption in Young Women J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3801 - 3807. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Campbell, J. C. Fleet, R. T. Hall, and N. S. Carnell Short-Term Low-Protein Intake Does Not Increase Serum Parathyroid Hormone Concentration in Humans J. Nutr., August 1, 2004; 134(8): 1900 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dawson-Hughes, S. S. Harris, H. Rasmussen, L. Song, and G. E. Dallal Effect of Dietary Protein Supplements on Calcium Excretion in Healthy Older Men and Women J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1169 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Farnsworth, N. D Luscombe, M. Noakes, G. Wittert, E. Argyiou, and P. M Clifton Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsulinemic men and women Am. J. Clinical Nutrition, July 1, 2003; 78(1): 31 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B Rapuri, J C. Gallagher, and V. Haynatzka Protein intake: effects on bone mineral density and the rate of bone loss in elderly women Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1517 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. K. (F. Roughead, L. K. Johnson, G. I. Lykken, and J. R. Hunt Controlled High Meat Diets Do Not Affect Calcium Retention or Indices of Bone Status in Healthy Postmenopausal Women J. Nutr., April 1, 2003; 133(4): 1020 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Kerstetter, K. O. O'Brien, and K. L. Insogna Low Protein Intake: The Impact on Calcium and Bone Homeostasis in Humans J. Nutr., March 1, 2003; 133(3): 855S - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Medeiros, A. Plattner, D. Jennings, and B. Stoecker Bone Morphology, Strength and Density Are Compromised in Iron-Deficient Rats and Exacerbated by Calcium Restriction J. Nutr., October 1, 2002; 132(10): 3135 - 3141. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dawson-Hughes and S. S Harris Calcium intake influences the association of protein intake with rates of bone loss in elderly men and women Am. J. Clinical Nutrition, April 1, 2002; 75(4): 773 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L Weinsier and C. L Krumdieck Dairy foods and bone health: examination of the evidence Am. J. Clinical Nutrition, September 1, 2000; 72(3): 681 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Wangen, A. M. Duncan, B. E. Merz-Demlow, X. Xu, R. Marcus, W. R. Phipps, and M. S. Kurzer Effects of Soy Isoflavones on Markers of Bone Turnover in Premenopausal and Postmenopausal Women J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3043 - 3048. [Abstract] [Full Text] |
||||
![]() |
J. E Kerstetter, C. M Svastisalee, D. M Caseria, M. E Mitnick, and K. L Insogna A threshold for low-protein-diet-induced elevations in parathyroid hormone Am. J. Clinical Nutrition, July 1, 2000; 72(1): 168 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Z. Ilich and J. E. Kerstetter Nutrition in Bone Health Revisited: A Story Beyond Calcium J. Am. Coll. Nutr., June 1, 2000; 19(6): 715 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Metges and C. A. Barth Metabolic Consequences of a High Dietary-Protein Intake in Adulthood: Assessment of the Available Evidence J. Nutr., April 1, 2000; 130(4): 886 - 889. [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |